Cite
HARVARD Citation
Abrishamian, L. et al. (n.d.). 1130. Ensovibep antiviral activity in ambulatory patients with COVID-19 is independent of baseline anti-SARS-CoV-2 antibodies and exhibits minimal selective pressure – Results from the placebo-controlled EMPATHY trial. Open forum infectious diseases. p. . [Online].